Covid-19
WHY THIS MATTERS IN BRIEF By future standards today’s medicines and treatments are old fashioned, and we have an increasing…
WHY THIS MATTERS IN BRIEF Animal testing is controversial, on the one hand it helps get drugs to market and…
WHY THIS MATTERS IN BRIEF Making and distributing billions of vaccines fast is difficult to say the least – this…
WHY THIS MATTERS IN BRIEF Being able to detect viruses in the blood and filter them out before they cause…
WHY THIS MATTERS IN BRIEF Manufacturing COVID-19 vaccines for billions of people is difficult and relies on having lots of…
WHY THIS MATTERS IN BRIEF Today we have multiple vaccines for multiple diseases, but what if one vaccine could protect…
WHY THIS MATTERS IN BRIEF The global pandemic has caused unimaginable havoc but as Sars-Cov-2 mutates there are fears vaccines…
WHY THIS MATTERS IN BRIEF Once you digitise something you can analyse it, share it, and run simulations that wouldn’t…
WHY THIS MATTERS IN BRIEF Being able to accurately model and predict how proteins fold has revolutionary implications for how…
WHY THIS MATTERS IN BRIEF A Covid-19 vaccine will hopefully get the world back to work, but the speed it’s…
WHY THIS MATTERS IN BRIEF Events are changing in a big way, and the Covid-19 lockdowns have encouraged some companies…
WHY THIS MATTERS IN BRIEF Cash, sooner or later, will die, and several countries are trialling its replacements. Interested…
